A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction

European Heart Journal

Volumn 27, Issue 9, 2006, Pages 1114-1122

  Freyman, Toby ^a   Polin, Glenn ^b   Osman, Hashim ^b   Crary, Jody ^a   Lu, MinMin ^b   Cheng, Lan ^b   Palasis, Maria ^a   Wilensky, Robert L ^b  

^a BOSTON SCIENTIFIC CORPORATION   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bone marrow derived stem cell; Endocardial; Intracoronary; Intravenous; Regeneration

Indexed keywords

IRIDIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENDOCARDIUM; EX VIVO STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HEART INFARCTION; INTERNALIZATION; INTRACORONARY INFUSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MESENCHYMAL STEM CELL; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STEM CELL TRANSPLANTATION;

ANIMALS; FEMALE; GRAFT SURVIVAL; INFUSIONS, INTRALESIONAL; INFUSIONS, INTRAVENOUS; INJECTIONS; IRIDIUM RADIOISOTOPES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL INFARCTION; RANDOM ALLOCATION; SWINE;

EID: 33646269967     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi818     Document Type: Article

References (31)

1. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapies. Circ Res 2004;95:9-20.
2. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, Sano M, Takahashi T, Hori S, Abe H, Hata J, Umezawa A, Ogawa S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999;103:697-705.
3. Mosca JD, Hendricks JK, Buyaner D, Davis-Sproul J, Chuang LC, Majumdar MK, Chopra R, Barry F, Murphy M, Thiede MA, Junker U, Rigg RJ, Forestell SP, Bohnlein E, Storb R, Sandmaier BM. Mesenchymal stem cells as vehicles for gene delivery. Clin Orthop 2000;379(Suppl.):S71-S90.
4. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocytes phenotype in the adult murine heart. Circulation 2002;105:93-98.
5. Kudo M, Wang Y, Wani MA, Xu M, Ayub A, Ashraf M. Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart. J Mol Cell Cardiol 2003;23:1113-1119.
6. Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM, Pittenger MF, Martin BJ. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 2002;73:1919-1925.
7. Wollert KC, Meyer GP, Lotz S, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomized controlled clinical trial. Lancet 2004;364:141-148.
8. Assmus B, Schächinger V, Teupe C, Britten M, Lehmann R, Döbert N, Grünwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher AM. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002;106:3009-3017.
9. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, Dzau VJ. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003;9:1195-1201.
10. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, Muul L, Hofmann T. Isolated allogenic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 2002;99:8932-8937.
11. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
12. Strauer BE, Brehm M, Zeus T, Köstering M, Hernandez A, Sorg RV, Kögler G, Wernet P. Repair of infarcted myocardium in autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106:1913-1918.
13. The TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. N Engl J Med 1985;312:932-936.
14. Askari AT, Unzek S, Popovic ZB, Goldman CK, Foruki F, Kiedrowski M, Rovner A, Ellis SG, Thomas JD, DiCorletto PE, Topol EJ, Penn MS. Effect of stromal-cell-derived factor 1 on stem-cell homing in ischaemic cardiomyopathy. Lancet 2003;362:697-703.
15. Frangioni JV, Hajjar RJ. In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation 2004;110:3378-3383.
16. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ. Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004;110:3300-3305.
17. Kloner RA, Ganote CE, Jennings RB. The 'no-reflow' phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54: 1496-1508.
18. Meisel SR, Shapiro H, Radnay J, Neuman Y, Khaskia AR, Gruener N, Pauzner H, David D. Increased expression of neutrophil and monocyte adhesion molecules LFA-1 and Mac-1 and their ligand ICAM-1 and VLA-4 throughout the acute phase of myocardial infarction. Possible implications for leukocyte aggregation and microvascular plugging. J Am Coll Cardiol 1998;31:120-125.
19. Taniyama Y, Ito H, Iwakura K, Masuyama T, Hori M, Takiuchi S, Nishikawa N, Higashino Y, Fujii K, Minamino T. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol 1997;30:1193-1199.
20. Reffelmann T, Hale SL, Dow JS, Kloner RA. No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion. Circulation 2003;108:2911-2917.
21. Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H, Matsui H, Toki Y, Ito T, Hayakawa T. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 2000;36:1202-1209.
22. Chen S, Fang W, Ye F, Liu Y, Qian J, Shan S, Zhang J, Chunhua R, Liao L, Lin S, Sun J. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. Am J Cardiol 2004;94:92-95.
23. Vuillet PR, Greeley M, Halloran SM, MacDonald KA, Kittleson MD. Intracoronary arterial injection of mesenchymal stomal cells and microinfarction in dogs. Lancet 2004;363:783-784.
24. Kang H, Kim H, Zhang S, Park K, Cho H, Koo B, Kim Y, Lee DS, Sohn D, Han K, Oh R, Lee M, Park Y. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulation factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004;363:751-756.
25. Kuramochi Y, Fukazawa R, Migita M, Hayakawa J, Hayashida M, Uchikoba Y, Fukumi D, Shimada AT, Ogawa S. Cardiomyocyte regeneration from circulating bone marrow cells in mice. Ped Res 2003;54:319-325.
26. Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, Miller L, Guetta E, Zipori D, Kedes LH, Kloner RA, Leor J. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium. Feasibility, migration and body distribution. Circulation 2003; 108:863-868.
27. Kraitchman DL, Tatsumi M, Gilson WD, Ishimori T, Kedziorek P, Segars WP, Chen HH, Fritzges D, Izbudak I, Young RG, Marceline M, Pittenger MF, Solaiyappan M, Boston RC, Tsui BMW, Wahl RL, Bulte JWM. Dynamic imaging of allogenic mesenchymal stem cells trafficking to myocardial infarction. Circulation 2005;112:1451-1461.
28. Penicka M, Widimsky P, Kobylka P, Kozak T, Lang O. Early tissue distribution of bone marrow mononuclear cells after transcoronary transplantation in a patient with acute myocardial infarction. Circulation 2005;112:e63.
29. Ito A, Hibino E, Honda H, Hata K, Kagami H, Ueda M, Kobayasho TA. A new methodology of mesenchymal stem cell expansion using magnetic nanoparticles. Biochem Eng J 2004;20:119-125.
30. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000;18:410-414.
31. Hinds KA, Hill JM, Shapiro EM, Laukkanen MO, Silva AC, Combs CA, Varney TR, Balaban RS, Koretsky AP, Dunbar CE. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 2003;102:867-872.